西罗莫司是一种新型大环内酯类免疫抑制剂,其能和FK506蛋白进行结合形成一种新的复合物,这种新的复合物能和哺乳类动物的西罗莫司靶点很好的进行结合,这样就能使得T淋巴细胞和其它细胞由G1期向S期的进程被阻断,这样也就是的免疫效应得到了发挥。另外,西罗莫司的独特作用还可以当做特殊的化疗药物运用到肿瘤治疗当中,其作用对很多癌症治疗都取得了令人满意的效果。根据本人的一些相关经验,谈谈对西罗莫司自微乳化释药系统的一些看法,与大家共同进行交流,希望对大家有所帮助。 Sirolimus, a novel macrolide immunosuppressant, binds to FK506 protein to form a new complex that binds to mammalian targets of sirolimus A good combination, so that we can make T lymphocytes and other cells from the G1 phase to S phase of the process is blocked, so that is the immune effect has been played. In addition, the unique role of sirolimus can also be used as a special chemotherapeutic drug in cancer therapy, its role for many cancer treatment have achieved satisfactory results. According to some of my own experience, to talk about the sirolimus self-microemulsifying drug delivery system, some of the views, and we share common exchanges, I hope to be helpful to everyone.